Alkermes Announces Positive Results From Two Clinical Trials of ALKS 33
Posted by: DrugsNews on: 13 Oct, 2009
- In: Drugs News| News
- Comment!
Alkermes Announces Positive Results From Two Clinical Trials of ALKS 33
— Novel Oral Molecule Has Potential Benefits in Addiction
and Other Central Nervous System Disorders —
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 13, 2009– Alkermes,
Inc. (NASDAQ: ALKS) today announced positive topline data from…
Read more about Alkermes Announces Positive Results From Two Clinical Trials of ALKS 33
| Indian Pharmacy! Looking for Generic Medications? Quality Drugs at affordable prices! Reliable Indian Pharmacy www.IndianPharmacy.org |
#1 Canadian Pharmacy Online! The Lowest Prices from Canadian Drugstore! Various payments, secure shopping, worldwide shipping! www.CanadianPharmacyLtd.org |
What are the Drugs-Review websites?
The Drugs-Review websites are NOT but will be your number one stop for all the latest news, comment and pharmaceutical industry information.
Related posts:
- Alkermes Announces Positive Results From Two Clinical Trials Of ALKS 33
- Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation
- Alkermes Announces Positive Results from Phase 3 Clinical Study of Naltrexone for Extended-Release Injectable Suspension for the Treatment of Opioid Dependence
